LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intende...
FDA Device Recall #Z-1529-2021 — Class II — April 6, 2021
Recall Summary
| Recall Number | Z-1529-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 6, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | LeMaitre Vascular, Inc. |
| Location | Burlington, MA |
| Product Type | Devices |
| Quantity | 616 units |
Product Description
LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intended to be used to perfuse contrast medias into the vessels for angiographic procedures, Catalog #: 4100-00.
Reason for Recall
The firm received a complaint regarding particulate found in the packaging foam that could contaminate the sterile field.
Distribution Pattern
Worldwide distribution - US Nationwide distribution in the states of AL, CA, FL, IL, IN, KY, MA, MO, NY, OH, TN, TX and the countries of Bahamas, Belgium, France, Germany, Hong Kong, Spain.
Lot / Code Information
Lot: LCI1091, LCI1092, LCI1093, LCI1094, LCI1095, LCI1096, LCI1097, LCI1098, LCI1099
Other Recalls from LeMaitre Vascular, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1574-2026 | Class II | Artegraft Vascular Graft; REF#: AG740; | Feb 10, 2026 |
| Z-0289-2026 | Class II | Artegraft¿ Collagen Vascular Graft; REF: AG1015; | Sep 25, 2025 |
| Z-0034-2026 | Class II | Artegraft Collagen Vascular Grafts Model Numbe... | Sep 2, 2025 |
| Z-0072-2026 | Class II | Artegraft Collagen Vascular Graft. Model/Catal... | Aug 25, 2025 |
| Z-1751-2025 | Class II | Pruitt Occlusion Catheter. Catalog Numbers: 210... | Apr 11, 2025 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.